Stock Screener App

무료 -

설치하다

41.10

6.41% 2.39

Viking Therapeutics Inc (VKTX)

개요 뉴스 가격 이력 옵션 체인 Financials VKTX 왜 하락? 토론 예측

Viking Therapeutics Inc (VKTX) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	-	-	-	-	-
Operating Expenses	67.14% 164.74	98.56	74.57	55.47	46.24
Operating Income/Loss	67.14% -164.74	-98.56	-74.57	-55.47	-46.24
Income/Loss From Continuing Operations Before Tax	73.66% -157.66	-90.79	-65.56	-45.63	-35.42
Income/Loss From Continuing Operations After Tax	73.66% -157.66	-90.79	-65.56	-45.63	-35.42
Net Income/Loss	73.66% -157.66	-90.79	-65.56	-45.63	-35.42
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.60% 0.45	112.32	112.13	112.07	0.775
Diluted Average Shares	99.60% 0.45	112.32	112.13	112.07	0.775
Basic Earnings Per Share	71.60% -1.39	-0.81	-0.58	-0.41	-0.32
Diluted Earnings Per Share	71.60% -1.39	-0.81	-0.58	-0.41	-0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INSM

$113.31

1.26%

ROIV

$35.27

0.23%

RPRX

$57.77

1.44%

MRNA

$78.94

3.59%

ONC

$307.27

0.67%

RVMD

$190.47

0.31%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개